IP Library › Granted Patent US 12,156,915
Granted Patent B2
US 12,156,915 · App. 17/433,594 · Granted Dec 3, 2024

Selected artemisinin dimers for the treatment of lashmaniasis

Inventors: Mahmoud A. ElSohly (Oxford, MS); Waseem Gul (Oxford, MS)
A61K47/55A61K47/542A61K47/545A61P33/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,156,915
App. No.
17/433,594
Granted
Dec 3, 2024
Kind
B2
Abstract

New compositions are provided containing artemisinin dimers with high activity as anti-protozoal agents, including anti-malarial and anti-leishmanial properties, and methods for the treatment of protozoal infections, including malaria or leishmaniasis.

Claims (3)

1. Artemisinin dimers having the formula:

2. A method of treating Leishmaniasis disease comprising administrating to a subject in need of such treatment an effective amount of at least one of the dimers according to claim 1 .

3. A pharmaceutical composition comprising at least one dimer according to claim 1 and a suitable pharmaceutical carrier.

Continuity (1)
Related Publication 20220175937A1 · Jun 9, 2022